Ctibiotech
Human tissue and 3D cell models with drug screening and preclinical testing for pharma and cosmetics firms
Highlights
- New on EvolcAdded 2026-11-02
About Ctibiotech
CTIBIOTECH develops advanced human tissues and 3D tissue and cell models for biomedical research, drug testing and cosmetics testing. Its work uses human tissues collected after surgery, stem cells and 3D printing, and includes patient-derived organoids and cancer screening systems. Services cover drug screening, toxicity testing, contract research and preclinical evaluation, and the company also sells human cells and tissues for use in customers' own labs.
Customers include cosmetics and pharmaceutical companies, biotech firms, cancer centres, hospitals and universities. The company earns revenue from testing and contract research services and from the sale of cells and tissues, and it works with distributors in its global network.
The company was founded in 2008 and is headquartered in Meyzieu, near Lyon, France, with a US office in Philadelphia. Its French laboratory is ISO 9001:2015 certified, and the website states that its tissues are used in more than 30 countries.
Product: 3D human tissue and cell models, cancer organoid screening systems, skin and pharmaceutical testing services, and human cells and tissues for lab use.
Jobs at Ctibiotech
Leadership
- Nico Forraz · CEO, France & USASource: company website
- Colin McGuckin · President France, Global CSOSource: company website
More biotech & pharma companies
Cure 51
Cancer target discovery platform using exceptional survivor biology for pharmaceutical and oncology research partnersYoung companyNew on EvolcCytoo
Muscle disease drug-discovery services and micropattern products for pharmaceutical, biotechnology and research organizationsNew on EvolcDBV Technologies
Develops VIASKIN epicutaneous immunotherapy patches for patients with food allergies and other immunological diseasesNew on EvolcDeeplife
AI-driven cell digital twins and multi-omics analysis for pharmaceutical drug discovery and developmentNew on EvolcDepixus
Magnetic force spectroscopy instruments for researchers studying biomolecular interactions and drug discoveryNew on EvolcDiogenx
Preclinical biotech developing regenerative protein therapies for type 1 diabetes, aimed at restoring insulin-producing beta cellsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- AstroMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- VueMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.